![igc-ad1](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_01-min-1024x1024.jpg)
August 20, 2020
IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients
Facebook
Twitter
LinkedIn